Clinical Outcomes and Predictors of Response to Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: A Retrospective Cohort Study over a 4-Year Period.

Pharmaceutics · 2026 · PMC13209947 · PMID 42198211

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

near-significantno p-value reported

Baseline regimen heterogeneity yielded no prognostic disparities except borderline biphasic dyskinesia modulation, with levodopa monotherapy patients showing enhanced post-switch gains; multivariable modeling confirmed PD duration as a near-significant covariate.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.